REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 23 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,320 | -19.6% | 14,000 | -3.5% | 0.00% | 0.0% |
| Q2 2023 | $84,975 | +232.3% | 14,501 | +137.6% | 0.00% | – |
| Q1 2023 | $25,575 | -11.7% | 6,104 | -10.4% | 0.00% | – |
| Q4 2022 | $28,959 | +2795.9% | 6,814 | +934.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 659 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 659 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 659 | +272.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 177 | -94.2% | 0.00% | – |
| Q1 2021 | $17,000 | – | 3,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |